Access Amylyx Stock and Financial Details

Amylyx stock price

Forge Price ¹

Price not available

Last Closed Trade ²

Close Date

xx/xx/xx

Last Closed Trade Price

$xx.xx

Last Funding Round (LFR)

Date

xx/xx/xx

Price per Share

$xx.xx

Access Stock Price

Amylyx funding rounds and valuation

Funding history chart

Funding round details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	07/20/2021	Series C-1	$107.33MM	$xx.xx	$541.01MM	683 Capital Management, Amoon Fund, Bain Capital Life Sciences, Belinda Termeer, Falcon Edge, Marshall Wace, Morningside Ventures, Perceptive Advisors, Polaris Founders Capital, Rock Springs Capital, Tybourne Capital Management, Verition Fund Management, Viking Global Investors, Woodline Partners
Price per Share $xx.xx Shares Outstanding 10,455,452 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 683 Capital Management, Amoon Fund, Bain Capital Life Sciences, Belinda Termeer, Falcon Edge, Marshall Wace, Morningside Ventures, Perceptive Advisors, Polaris Founders Capital, Rock Springs Capital, Tybourne Capital Management, Verition Fund Management, Viking Global Investors, Woodline Partners
	07/20/2021	Series C-2	$27.67MM	$xx.xx	$541.01MM	683 Capital Management, Amoon Fund, Bain Capital Life Sciences, Belinda Termeer, Falcon Edge, Marshall Wace, Morningside Ventures, Perceptive Advisors, Polaris Founders Capital, Rock Springs Capital, Tybourne Capital Management, Verition Fund Management, Viking Global Investors, Woodline Partners
Price per Share $xx.xx Shares Outstanding 3,170,585 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 683 Capital Management, Amoon Fund, Bain Capital Life Sciences, Belinda Termeer, Falcon Edge, Marshall Wace, Morningside Ventures, Perceptive Advisors, Polaris Founders Capital, Rock Springs Capital, Tybourne Capital Management, Verition Fund Management, Viking Global Investors, Woodline Partners
	07/01/2020	Series B	$60.52MM	$xx.xx	$477.95MM	Drads Capital, Morningside Ventures
Price per Share $xx.xx Shares Outstanding 3,565,494 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.2x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Drads Capital, Morningside Ventures
	08/23/2016	Series A	$7.73MM	$xx.xx	$22.09MM	Als Investment Fund, Lysosomal Therapeutics, Morningside Ventures
Price per Share $xx.xx Shares Outstanding 6,289,609 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Als Investment Fund, Lysosomal Therapeutics, Morningside Ventures

Access Stock Price

Company details

Amylyx is a pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases. Amylyx was founded in 2013 by Joshua Cohen and is headquartered in Cambridge, MA.

amylyx.com

Sector

Healthcare

Subsector

Biotech & Pharma

Founded

2014

Headquarters

Cambridge, MA, United States

Post-Money Valuation ³

$541.01MM

Total Funding

$203.25MM

LFR Price per Share

$xx.xx

Last Funding Share Class

Series C-1

Amylyx stock FAQs

To buy and sell Amylyx stock

Can you buy Amylyx stock?

You can no longer buy Amylyx stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Amylyx stock?

Can you sell Amylyx stock?

You can no longer sell stock of Amylyx on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Amylyx stock?

To learn more about Amylyx stock

Is Amylyx a public company?

Amylyx is now a public company traded on NASDAQ with ticker AMLX.

What is Amylyx’s stock price?

The stock price of Amylyx is $14.88 as of 1/18/24.

What is Amylyx’s stock ticker symbol?

The ticker symbol of Amylyx is AMLX.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Explore private companies in the Biotech & Pharma sector

Sector: Healthcare

Subsector: Biotech & Pharma

					Last Funding Round
Company		Forge Price	Forge Price Change ⁵	Last Closed Trade	Share Class	Post-Money Valuation	Price per Share	Amount Raised
	Altos Labs	--	--	$xx.xx	Series C	$6.33B	$xx.xx	$1.5B
	Apnimed	--	--	$xx.xx	Series D	$394.07MM	$xx.xx	$16.5MM
	Colossal Biosciences	--	--	$xx.xx	Series C	$10.2B	$xx.xx	$200MM
	Egenesis	--	--	$xx.xx	Series D	$332.59MM	$xx.xx	$90.96MM
	Isomorphic Labs	--	--	$xx.xx	--	--	--	--
	Life Biosciences	--	--	$xx.xx	--	--	--	--
	Loyal	--	--	$xx.xx	Series B-5	$428.44MM	$xx.xx	$17.49MM
	Mammoth Biosciences	--	--	$xx.xx	Series D-2	$1.35B	$xx.xx	$107.74MM
	Strand Therapeutics	--	--	$xx.xx	Series B-2	$567.33MM	$xx.xx	$120MM
	Tessera	--	--	$xx.xx	Series D	$776.64MM	$xx.xx	$200MM

See All Companies

Forge is your trusted partner to buy and sell Amylyx stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Mar 8, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Amylyx stock